Cyanamid of Wayne, N.J., named Vincent T. Marchesi to itsboard of directors. He is director of the Yale Center forMolecular Medicine and professor of pathology, biology and cellbiology at the Yale University School of Medicine.
Antonius Berns was named executive vice president ofresearch and development at Somatix Therapy Corp. ofAlameda, Calif. He is head of the division of molecular geneticsat The Netherlands Cancer Institute in Amsterdam.
Genetics Institute Inc. of Cambridge, Mass., said that Joseph J.Jacobs has resigned from the company's board of directors.
(c) 1997 American Health Consultants. All rights reserved.